Navigation Links
Rare Bone Disease Traced To Faulty FOP Gene

The mystery surrounding a rare bone disease called fibrodysplasia ossificans progressiva (FOP) has been resolved following the identification of a mutant gene// linked to the disease. It is this gene that triggers the formation of a second skeleton, making movement impossible. Nearly 2500 individuals are believed to be afflicted with the disease, worldwide.

As the disease progresses, the muscles, ligaments, tendons, and plates of bones are imprisoned in the second skeleton, for the entire life. The disease that occurs in early childhood has no proper available treatment.

The identification of this mutant FOP gene could eventually pave for development of novel treatment techniques to treat the disease. Additionally, it might provide important clues about effective treatment of head injuries, spinal trauma and sports injuries.

The researchers at Penn's Center for Research in FOP and Related Disorders were involved in 15 years of hard work to analyze the genetic constitution of the families associated with the disease. Mutation in a single gene called ACVR1 was pinpointed to be the cause of FOP. 'We've reached the summit. The genetic twist that leads to FOP, is relevant to every condition that affects the formation of bone and every condition that affects the formation of the skeleton,' said Dr. Frederick Kaplan, in a telephonic interview, commenting about the discovery.

The results of this study, published in the online edition of the Nature journal, could lead to the development of drugs that would inhibit or bypass the genetic switch that triggers extra bone growth. Perhaps, some day, it might even be possible to prevent formation of the unnecessary bone that occasionally forms after hip-replacement surgery. It could also lead to an improved understanding of other similar bone related diseases.

'In the next five years, this might open up the possibility of developing drugs that would be effective in stoppin g bone formation. The first thing that comes to mind is osteoporosis, which is the flip side of the coin when it comes to bone formation. When one learns about one side - extra bone growth - it helps you understand what goes the other way,' said Dr. Victor A. McKusick, a genetics pioneer and professor of medical genetics at Johns Hopkins University School of Medicine in Baltimore.

'If they develop a pill we can take every day, I can move and do more things, and it might be easier for me to become a vet, like I've always wanted to,' said Stephanie Snow, a FOP sufferer, who aspires becoming a veterinarian.

'The gene discovery is an extraordinary gift to the FOP community and a monumental milestone on our road to a cure,' said Jeannie Peeper, a 47-year-old FOP patient, member of International FOP Association, who is set to defy all odds despite her total immobility.

This novel breakthrough has indeed offered endless hope to numerous victims, afflicted with FOP.

Related medicine news :

1. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
2. Vitamins-The answer to Heart Disease?
3. Link between Constipation and Parkinsons Disease
4. Levels Of Blood Proteins May Help Heart Disease Care
5. New Drug PP188 Helps Sickle Cell Disease
6. Gene Treatment for Heart Disease
7. Legume Consumption Can Cut Heart Disease Risk
8. Link Between Infection And Heart Disease
9. Celiac Disease in Type 1 Diabetes
10. Shunt for Alzheimers Disease
11. High iron levels may cause Cardiovascular Disease in women
Post Your Comments:

(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
Breaking Medicine Technology: